About Leucine
Leucine is a Technology company based in Wilmington (United States) founded in 2015 by Vivek Gera and Mustaq Singh Bijral. It operates in the Technology, Healthcare, and Industrial Goods & Manufacturing sectors. Leucine has raised $7.68 million across 3 funding rounds from investors including Ecolab, Pravega Ventures and Axilor Ventures. Leucine was last valued at $3.22 million in June 2020. Its chief executive, as recorded, is Vivek Gera. Its website leucine.io draws about 18 thousand monthly visits. Its Indian entity Leucine Medtech Private Limited reported revenue of ₹16.2 Lakh. Leucine offers products and services including Manufacturing Execution System, Quality Management System, Laboratory Execution System, Batch Execution, and AI Investigator. Its focus areas include HealthTech, Life Sciences Tech, Manufacturing and AI Based. Its competitors include Advarra, Cogniac and MasterControl; 2 of its 3 listed competitors have raised funding.
Company details
Developer of AI-powered software for pharmaceutical manufacturing, quality, and laboratory. The platform integrates manufacturing execution, quality management, and laboratory operations into a unified digital ecosystem. It offers solutions for batch execution, quality control, environmental monitoring, and instrument management. The software aims to streamline workflows, ensure regulatory compliance, and optimize operational efficiency within pharmaceutical facilities.
- Headquarters Wilmington, United States
- Founders Vivek Gera, Mustaq Singh Bijral
- Stage Minicorn
- SectorsTechnologyHealthcare Industrial Goods & Manufacturing
- Email••••••••
- Phone•••• ••••
- Website leucine.io
- Social LinkedIn X YouTube
- Legal Name Leucine Medtech Private Limited
- Date of Incorporation 22 Apr, 2015
- Jurisdiction Sri Ganganagar, Rajasthan, India
- Indian entity revenue₹16.2 Lakh
FY 2024 · -80% YoY
- Indian entity net profit₹11.6 Lakh
FY 2024 · 72% margin
- Indian entity EBITDA₹13.7 Lakh
FY 2024 · 84% margin
- Total Equity Funding$7.68M (USD)
in 3 rounds
- Latest Funding Round$7M (USD), Series A
Oct 2023
- InvestorsEcolab
& 5 more
Associated legal entities of Leucine
Leucine operates through Leucine Medtech Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Leucine Medtech Private Limited CIN U15400RJ2015PTC047406 | Active | 22 Apr 2015 | Sri Ganganagar, Rajasthan | ₹0.2 Cr | 2 | View details |
Products & Services of Leucine
Leucine offers a comprehensive portfolio of products and services, including Manufacturing Execution System, Quality Management System, Laboratory Execution System, Batch Execution, and AI Investigator.
Streamlines workflows for efficient batch execution and compliance
Manages documentation and automates compliance risk alerts
Orchestrates operations for faster turnaround and error reduction
Digitizes manufacturing workflows to ensure accurate execution
Accelerates investigations for regulatory and quality issues
Apps and channels of Leucine
its YouTube channel Leucine has 252 subscribers and 12 videos.
Videos from Leucine
The most watched videos on Leucine's YouTube channel, Leucine (252 subscribers). Click a video to play it here.
More on Leucine.
Funding Insights of Leucine
Leucine has successfully raised a total of $7.68M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $7 million completed in October 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $7.68M
- Total Rounds 3
- Last Round Series A — $7M
- First Round $19,755
(May 2019)
- Investors Count 6
All 3 funding rounds of Leucine with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2023 | $7M | Series A | – | Ecolab | |
| Jun 2020 | $658,800 | Seed | $3.22M | Pravega Ventures | |
| May 2019 | $19,755 | Seed | $331,317 | Techstars | – |
| Date | Valuation | Stage |
|---|---|---|
| Jun 2020 | $3.22M | •••••••• |
Last known valuation $3.22M (Jun 2020). 6 investors in total: 4 institutional and 2 angel.
Investors in Leucine
Leucine has secured backing from 6 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Ecolab, Pravega Ventures and Axilor Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Financial services, strategic advisory, and partnerships in investments. | pravegavc.com | Bengaluru, India | ||
Venture capital firm investing in early-stage startups in technology sectors. | 2014 | axilor.com | Bengaluru, India | |
Startups are accelerated globally without sector restrictions through structured programs. | 2006 | techstars.com | New York, United States | |
Tech-enabled water-efficient products are supplied for global industries. | 1923 | ecolab.com | Saint Paul, United States | |
DK Dilipkumar Khandelwal | unknown_ea4064ed8acf4d328 | |||
AG Abhishek Goyal | Founder of Tracxn, active angel investor in Indian startups | unknown_e8bb43fea0334072b |
Investor details for Leucine
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Leucine Medtech Private Limited (Leucine)
Leucine Medtech Private Limited is the primary company behind Leucine. The board of Leucine Medtech Private Limited currently have 2 directors; the longest-serving is Vivek Gera, appointed in 2015. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Vivek Gera DIN 07134226 | Director | 22 Apr 2015 | 11 yrs 6 mo | Leucine Medtech Private Limited |
| Mustaq Singh Bijral DIN 07247299 | Director | 06 Jan 2020 | 6 yrs 9 mo | Leucine Medtech Private Limited |
People of Leucine
2 people are tracked at Leucine (2 in leadership).
| Name | Role | Group |
|---|---|---|
| Co-Founder & CEO | Leadership | |
| Co-Founder & Head of Product | Leadership |
Complete people profiles for Leucine
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Leucine
Figures of Leucine Medtech Private Limited, the primary company behind Leucine, for FY 2024. Revenue was ₹16.2 Lakh (-80% year on year). Net profit was ₹11.6 Lakh (72% margin). EBITDA was ₹13.7 Lakh (84% margin). Revenue has grown at a compounded annual rate of -52% over three years and +30% over five years.
- ₹16.2 LakhRevenue · FY 2024 · -80% YoY
- ₹11.6 LakhNet profit · 72% margin
- ₹13.7 LakhEBITDA · 84% margin
- ₹1.5 LakhPaid-up capital
- -52%Revenue CAGR, 3 years
- +30%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Leucine Medtech Private Limited are on its company page.
Detailed financial statements for Leucine
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Leucine
4 dated milestones of Leucine across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Leucine is founded.
- Funding First funding round of $20K.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Series A, of $7.0M.
Competitors of Leucine
Leucine has 3 listed competitors in our database, 2 of them funded. They include Advarra, Cogniac and MasterControl.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| advarra.com | 2017 | Columbia, United States | 642 | Global research compliance services including IRB and consulting are provided. | ||
| cogniac.ai | 2015 | San Jose, United States | $45.79M | 37 | AI-based platform is utilized for managing visual operations in businesses. | |
| mastercontrol.com | 1994 | Salt Lake, United States | $150M | 560 | Provider of governance, risk and compliance solutions for life sciences industries |
Detailed competitors of Leucine
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Leucine
The website of Leucine (leucine.io) receives about 17.8K visits a month.
- Monthly visits17.8K
▲ 62.9% vs previous month
Websites whose visitors overlap most with Leucine. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| wellfound.com | 100% | 4.4M | #12,474 | View details | |
fda483s.com | fda483s.com | 34% | #7,706,462 | – |
Top companies in GRC, Risk & Compliance Software
3 companies that operate in the same segment as Leucine (GRC, Risk & Compliance Software) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Cybersecurity and zero trust solutions are delivered for secure networks. | 2007 | San Jose, California, United States | USD 148 M | USD 3.35 B | 9,616 | |
Platform that provides data analysis and management solutions | 2003 | Denver, Colorado, United States | USD 2.46 B | USD 2.87 B | 5,915 | |
Identity and access management solutions are provided for developers. | 2013 | Bellevue, Washington, United States | USD 332.75 M | 350 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Leucine
Complete news archive for Leucine
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Leucine
Leucine was founded in 2015 and raised its 1st funding round 4 years after it was founded.
Leucine is headquartered in Wilmington, United States. It is registered at Wilmington, Delaware, United States.
Vivek Gera is the CEO of Leucine, as recorded in our data. They have also founded this company.
Leucine is a funded company, having raised a total of $7.68M across 3 funding rounds to date. The company's 1st funding round was a Seed of $19.76K, raised on May 2019.
The primary company behind Leucine, Leucine Medtech Private Limited, reported revenue of ₹16.2 Lakh for FY 2024, down 80% year on year.
Developer of AI-powered software for pharmaceutical manufacturing, quality, and laboratory. The platform integrates manufacturing execution, quality management, and laboratory operations into a unified digital ecosystem. It offers solutions for batch execution, quality control, environmental monitoring, and instrument management. The software aims to streamline workflows, ensure regulatory compliance, and optimize operational efficiency within pharmaceutical facilities.
Leucine's top competitors include Advarra, MasterControl and Cogniac.
Leucine offers Manufacturing Execution System, Quality Management System, Laboratory Execution System, Batch Execution, and AI Investigator.
Leucine has 6 investors. Key investors include Ecolab, Pravega Ventures, Axilor Ventures, Techstars, and Dilipkumar Khandelwal.
The valuation of Leucine is $3.22M as of Jun 2020.
Leucine operates through Leucine Medtech Private Limited.
The legal entities of Leucine currently have 2 directors, including Mustaq Singh Bijral, Vivek Gera.